Near-Infrared Spectroscopy in Pediatric Congenital Heart Disease.
Katherine L Zaleski, Barry D Kussman
https://pubmed.ncbi.nlm.nih.gov/31582201/Actively Recruiting
Led by Robert G. Webster, MD, MPH · Updated on 2026-10-01
46
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating whether temporarily increasing the heart rate in children after congenital cardiac surgery can improve blood flow and oxygen delivery to the bodys tissues. The study compares temporary atrial pacing at 10 and 20 beats per minute above the childs natural heart rate with the childs natural heart rate without pacing during the early postoperative period. Participants are grouped by heart physiology and serve as their own control in this randomized, crossover study. The study involves three heart rate conditions intrinsic sinus rhythm, temporary atrial pacing at 10 beats per minute above intrinsic rate, and temporary atrial pacing at 20 beats per minute above intrinsic rate. Each condition lasts about three hours, and participants are randomly assigned to one of two sequences that determine the order of these conditions during the first 10 hours after surgery. Temporary atrial pacing is delivered using epicardial pacing wires placed during surgery, and pacing adjustments may be made by the clinical team as needed. Participants stay in the cardiac intensive care unit where continuous physiologic data are collected using standard monitoring platforms. Measurements include near-infrared spectroscopy of the kidneys and brain, arterial pressure and oxygen saturation, venous pressure, airway pressure, blood lactate, pH, bicarbonate levels, and heart rate during each pacing condition. Pacing wire electrical properties are also assessed up to three days after surgery when clinically appropriate. Data collection and monitoring occur throughout the postoperative hospitalization, with no additional research-only procedures required.
CONDITIONS
Postoperative Pacing for Cardiac Efficiency
R
Robert G Webster, MD, MPH
J
Jeff Hong, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Robert G. Webster, MD, MPH
Lead Sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Atrial pacing +10 bpm | No protocol-directed pacing | Atrial pacing +20 bpm |
|---|---|---|---|
| What it is | Temporary epicardial atrial pacing is delivered at 10 beats per minute above the participant's baseline sinus rate during assigned periods in the early postoperative phase. | Participant's natural sinus rhythm, with no protocol-directed atrial pacing applied following congenital heart surgery. | Temporary epicardial atrial pacing is delivered at 20 beats per minute above the participant's baseline sinus rate during assigned periods in the early postoperative phase. |
| Role in trial | Evaluated as one type of protocol-directed pacing; compared directly against intrinsic rhythm and +20 bpm pacing to assess physiological effects. | Serves as the internal control condition for within-patient crossover comparison in the trial. | Evaluated as a higher-rate protocol-directed pacing intervention, compared against intrinsic rhythm and +10 bpm pacing. |
| Primary use | Assesses effects of mild increase in atrial pacing rate on hemodynamics and tissue oxygenation after pediatric cardiac surgery. | Acts as the baseline state; allows assessment of the participant's post-surgical cardiac function without intervention. | Assesses effects of a more pronounced increase in atrial pacing rate on hemodynamics and tissue oxygenation after pediatric cardiac surgery. |
| How it is given or performed | Temporary epicardial atrial pacing via wires placed during surgery, set to 10 beats per minute above measured intrinsic heart rate, maintained for approximately 3 hours. | No protocol-directed pacing is performed; patient remains in intrinsic rhythm during this condition. | Temporary epicardial atrial pacing via wires placed during surgery, set to 20 beats per minute above measured intrinsic heart rate, maintained for approximately 3 hours. |
| Evidence status | No published outcome data yet from this trial. Past observational studies and small trials report that temporary atrial pacing may improve cardiac output in select pediatric post-surgical populations, but optimal pacing rate and patient selection are uncertain. | No published data yet from this trial; non-intervention intrinsic rhythm is standard for physiological comparison. Past literature describes physiologic and hemodynamic monitoring post-cardiac surgery in children. | No published outcome data yet from this trial. Limited evidence supports higher pacing rates potentially improving hemodynamics in some cases, but data are variable and risk of adverse effects may increase at excessive rates. |
| Important limitations | Effects of +10 bpm pacing may vary significantly between patients. Potential confounders include residual hemodynamic instability, pre-existing arrhythmia risk, and medication effects. Results from small crossover protocols may not generalize widely. | Intrinsic rhythm condition may be affected by variable patient factors, such as post-surgical pain, medications, and clinical instability, independent of pacing intervention. | Data on higher pacing rates are particularly limited in very young children. Potential for hemodynamic benefit must be balanced against increased risk of tachyarrhythmia, myocardial oxygen demand, or intolerance, especially in unstable patients. Individualized exclusions and interruptions are frequent. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 10 hours
Participants experience three heart rate conditions: natural sinus rhythm, atrial pacing at 20 beats per minute above natural rate, and atrial pacing at 10 beats per minute above natural rate. Each condition lasts about three hours during the first 10 hours after surgery, with the order randomly assigned.
Continuous monitoring during postoperative hospitalization
Duration - Up to 3 days post-surgery
Electrical properties of pacing wires are assessed up to three days after surgery when clinically appropriate. Data collection continues through the postoperative hospitalization with no additional research-only procedures required.
Daily assessments as clinically indicated
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Katherine L Zaleski, Barry D Kussman
https://pubmed.ncbi.nlm.nih.gov/31582201/S Coates, B Thwaites
https://pubmed.ncbi.nlm.nih.gov/10962751/Rohit S Loomba, Enrique G Villarreal, Juan S Farias...
https://pubmed.ncbi.nlm.nih.gov/38783789/Gabe E Owens, Karen King, James G Gurney...
https://pubmed.ncbi.nlm.nih.gov/21085945/Qing Wang, Chuikai Chen, Li Wang
https://pubmed.ncbi.nlm.nih.gov/34252370/Brian Mendel, Christianto Christianto, Moira Setiawan...
https://pubmed.ncbi.nlm.nih.gov/34082685/S S Barold, L S Ong, R A Heinle
https://pubmed.ncbi.nlm.nih.gov/7019961/Monika Chauhan, Elizabeth Prentice, Marwan Zidan...
https://pubmed.ncbi.nlm.nih.gov/24681035/Gregory M Barker, Jeremy Affolter, Jessica Saenz...
https://pubmed.ncbi.nlm.nih.gov/23503930/Marek Jastrzębski, Paweł Moskal, Agnieszka Bednarek...
https://pubmed.ncbi.nlm.nih.gov/31181375/Robert G. Webster, MD, MPH
Lead Sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Collaborating Sponsor